Antonio Luca Spiezia
Overview
Explore the profile of Antonio Luca Spiezia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esposito A, Falco F, Scalia G, Gentile L, Spiezia A, Corsini G, et al.
Eur J Neurol
. 2024 Oct;
32(1):e16536.
PMID: 39475271
Background And Purpose: CD20 T lymphocytes are a subset of circulating T cells presenting the CD20 receptor, a molecular marker of B lineage. CD20 T lymphocytes are thought to play...
2.
Carotenuto A, Di Monaco C, Papetti L, Borriello G, Signoriello E, Masciulli C, et al.
J Neurol
. 2024 Aug;
271(10):6773-6781.
PMID: 39177751
Background: Pediatric-onset Multiple Sclerosis (POMS) patients show more inflammatory disease compared with adult-onset MS. However, highly effective treatments are limited with only fingolimod being approved in Italy and natalizumab prescribed...
3.
Falco F, Lamagna F, Esposito A, Eliano M, Spiezia A, Petracca M, et al.
Mult Scler Relat Disord
. 2024 Jul;
90:105769.
PMID: 39067188
Background: Fatigue is a common symptom in Multiple Sclerosis (MS), but its determinants are not clarified yet. Sensory processing sensitivity (SPS) is a personality trait characterized by enhanced sensitivity towards...
4.
Signoriello E, Signori A, Lus G, Romano G, Marfia G, Landi D, et al.
Mult Scler Relat Disord
. 2024 May;
87:105594.
PMID: 38718748
Background: in the early stages of Multiple Sclerosis (MS), initiating high-efficacy disease-modifying therapy (HE DMTs) may represent an optimal strategy for delaying neurological damage and long-term disease progression, especially in...
5.
Spiezia A, Scalia G, Petracca M, Caliendo D, Moccia M, Fiore A, et al.
J Neurol
. 2024 Apr;
271(7):4281-4291.
PMID: 38632126
Background: Circulating immune cells play a pathogenic role in multiple sclerosis (MS). However, the role of specific lymphocyte subpopulations is not unveiled yet, especially in progressive stages. We aimed to...
6.
Maida E, Moccia M, Palladino R, Borriello G, Affinito G, Clerico M, et al.
J Neurol
. 2024 Apr;
271(7):4057-4066.
PMID: 38568227
Background: ChatGPT is an open-source natural language processing software that replies to users' queries. We conducted a cross-sectional study to assess people living with Multiple Sclerosis' (PwMS) preferences, satisfaction, and...
7.
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis
Spiezia A, Falco F, Manganelli A, Carotenuto A, Petracca M, Novarella F, et al.
Mult Scler Relat Disord
. 2023 Oct;
79:105044.
PMID: 37837668
Background: Cognitive impairment frequently affects people with multiple sclerosis (MS). Low vitamin D has been associated with cognitive dysfunction in different neurodegenerative diseases, and, in MS, with motor disability and...
8.
Trinchillo A, Spiezia A, Carotenuto A, Tedeschi E, Servillo G, Iacovazzo C, et al.
Neurol Sci
. 2023 Mar;
44(7):2633.
PMID: 36977958
No abstract available.
9.
Trinchillo A, Spiezia A, Carotenuto A, Tedeschi E, Servillo G, Iacovazzo C, et al.
Neurol Sci
. 2023 Mar;
44(7):2305-2309.
PMID: 36930389
Background: To date, few cases of multiple sclerosis (MS) patients with concomitant Human Immunodeficiency Virus (HIV) infection have been described. However, none of the previously described cases has been treated...
10.
Spiezia A, Carotenuto A, Iovino A, Moccia M, Gastaldi M, Iodice R, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36498887
(1) The co-occurrence of AQP4 and myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with demyelinating disorders is extremely rare. In addition, a concomitant involvement of the peripheral nervous system (PNS)...